{"id":"W2949752825","doi":"10.1097/01.hs9.0000561220.73976.40","title":"PF734 PATIENT PREFERENCES FOR THE TREATMENT OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA: RESULTS OF A PATIENT SURVEY OF RAVULIZUMAB (ALXN1210) AND ECULIZUMAB","year":2019,"lang":"en","type":"article","venue":"HemaSphere","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Eculizumab; Paroxysmal nocturnal hemoglobinuria; Medicine; Dosing; Clinical trial; Pediatrics; Internal medicine; Immunology; Antibody","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001595965,0.0001731458,0.0003540622,0.0003128263,0.0003777179,0.00039967,0.0001373498,0.000500583,0.00214932],"category_scores_gemma":[0.005106491,0.0001028965,0.0007769631,0.0004347525,0.0001625557,0.0004633737,0.0003173644,0.0005099375,0.0002915791],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003841895,"about_ca_system_score_gemma":0.0002748116,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002760752,"about_ca_topic_score_gemma":0.002301466,"domain_scores_codex":[0.9988183,0.0005869098,0.0001369421,0.0001155053,0.0002081378,0.0001342018],"domain_scores_gemma":[0.996167,0.001039822,0.001917215,0.0001180718,0.0002728278,0.0004850015],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00328706,0.0006185651,0.9791017,0.00006567392,0.0003065447,0.0001208697,0.0004827591,0.0002574197,0.0004637476,0.00004764511,0.001163283,0.01408473],"study_design_scores_gemma":[0.0001927231,0.00202821,0.9949272,0.00001867939,0.0000846496,0.0003791663,0.0005557614,0.0007896168,0.0001529475,0.00003289982,0.0008203253,0.00001790996],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9986593,0.0001585011,0.00004722922,0.00009727678,0.000005531856,0.00002957291,0.0003898081,0.000003127169,0.0006097503],"genre_scores_gemma":[0.9994044,0.00006448959,0.00007008917,0.00009300399,0.000007388127,0.00002815314,0.0002016408,8.825415e-7,0.0001298371],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002760752,"threshold_uncertainty_score":0.008440316,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02348369215930301,"score_gpt":0.2527574460414279,"score_spread":0.2292737538821248,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}